P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling.
P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling.
复制标题
DOI:
10.1186/1471-2407-7-15
复制
发表时间:
2007-01-19
期刊:
影响因子:
3.8
通讯作者:
Kikkawa F
中科院分区:
文献类型:
--
作者:
Shibata K;Kajiyama H;Ino K;Nawa A;Nomura S;Mizutani S;Kikkawa F
Hyperglycemia or hyperinsulinemia contributes to poorer endometrial cancer survival. It was shown that P-LAP/IRAP translocates to the plasma membrane in response to insulin stimulation. Recently, we demonstrated that P-LAP/IRAP is associated with a poor prognosis in endometrial adenocarcinoma patients. The aim of this study was to examine whether the malignant potential of endometrial cancer enhanced by P-LAP/IRAP is due to increased glucose uptake via the P-LAP/IRAP-mediated activation of insulin signaling. We transfected P-LAP/IRAP cDNA into A-MEC cells (endometrial adenocarcinoma cell line), and A-MEC-LAP cells expressed a remarkably high level of GLUT4 proteins. 3H-2-deoxyglucose uptake which responds to insulin in A-MEC-LAP cells was significantly higher than that of A-MEC-pc cells. A-MEC-LAP cells exhibited a significant growth-stimulatory effect compared to A-MEC-pc cells. A-MEC-LAP cells expressed a remarkably high level of p85PI3K protein compared to A-MEC-pc cells, and showed a higher degree of AKT phosphorylation by insulin stimulation. In summary, P-LAP/IRAP was involved in the increasing malignant potential of endometrial cancer mediated by insulin. P-LAP/IRAP was suggested to be a potential new target of molecular-targeted therapy for endometrial cancer.
登录
查看更多内容
影响因子:
6.4
作者:
Kondo, C;Shibata, K;Kikkawa, F
通讯作者:
Kikkawa, F
影响因子:
4.5
作者:
Thoidis, G;Kandror, KV
通讯作者:
Kandror, KV
影响因子:
4.7
作者:
Shibata, K;Kikkawa, F;Mizutani, S
通讯作者:
Mizutani, S
影响因子:
6.4
作者:
Oki, E;Baba, H;Maehara, Y
通讯作者:
Maehara, Y
影响因子:
3.5
作者:
Shibata, K;Kikkawa, F;Mizutani, S
通讯作者:
Mizutani, S